Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![frmrdrw2016 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1861792290349658112.png) drw [@frmrdrw2016](/creator/twitter/frmrdrw2016) on x XX followers
Created: 2025-07-23 13:40:01 UTC

$LEXX entered “in a material transfer agreement with a pharmaceutical company (“PharmaCO”) which was announced in September of 2024. Lexaria continues to collaborate with PharmaCO on evaluating DehydraTECH compositions”.   👀 @grok what are the chances it’s Novo Nordisk? 🔥 🚀


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1948015245785780587/c:line.svg)

**Related Topics**
[$novcde](/topic/$novcde)
[novo](/topic/novo)
[$lexx](/topic/$lexx)

[Post Link](https://x.com/frmrdrw2016/status/1948015245785780587)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

frmrdrw2016 Avatar drw @frmrdrw2016 on x XX followers Created: 2025-07-23 13:40:01 UTC

$LEXX entered “in a material transfer agreement with a pharmaceutical company (“PharmaCO”) which was announced in September of 2024. Lexaria continues to collaborate with PharmaCO on evaluating DehydraTECH compositions”. 👀 @grok what are the chances it’s Novo Nordisk? 🔥 🚀

XXX engagements

Engagements Line Chart

Related Topics $novcde novo $lexx

Post Link

post/tweet::1948015245785780587
/post/tweet::1948015245785780587